Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:2108-2114
Published online before print May 31, 2007, doi: 10.1161/STROKEAHA.107.485631
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/7/2108    most recent
STROKEAHA.107.485631v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cramer, S. C.
Right arrow Articles by Himes, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cramer, S. C.
Right arrow Articles by Himes, D. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Other Stroke Treatment - Medical
Right arrow Acute Stroke Syndromes
Right arrow Rehabilitation, Stroke
Right arrowRelated Article

(Stroke. 2007;38:2108.)
© 2007 American Heart Association, Inc.


Original Contributions

Predicting Functional Gains in a Stroke Trial

Steven C. Cramer, MD; Todd B. Parrish, PhD; Robert M. Levy, MD, PhD; Glenn T. Stebbins, PhD; Sean D. Ruland, DO; David W. Lowry, MD; Theodore P. Trouard, PhD; Scott W. Squire; Martin E. Weinand, MD; Cary R. Savage, PhD; Steven B. Wilkinson, MD; Jenifer Juranek, PhD; Szu-Yun Leu, PhD David M. Himes, BS

From the Departments of Anatomy and Neurobiology (S.C.C., J.J.) and the General Clinical Research Center Biostatistics (S.-Y.L.), University of California, Irvine; Irvine, Calif; the Departments of Radiology (T.B.P.) and Neurological Surgery (R.M.L.), Northwestern University Feinberg School of Medicine, Chicago, Ill; the Department of Neurological Sciences (G.T.S.), Rush University Medical Center, Chicago, Ill; the Departments of Neurology and Rehabilitation (S.D.R.), University of Illinois at Chicago; Chicago, Ill; The Brain and Spine Center (D.W.L.); Holland, Mich; the Arizona Research Labs–Interdisciplinary (T.P.T.) and the Departments of Radiology (S.W.S.) and Neurosurgery (M.E.W.), University of Arizona; Tucson, Ariz; the Hoglund Brain Imaging Center and the Department of Psychiatry (C.R.S.), University of Kansas Medical Center, Kansas City, Kan; Midwest Brain and Spine Associates (S.B.W.), Independence, Mo; and Northstar Neuroscience, Inc (D.M.H.), Seattle, Wash

Correspondence to Steven C. Cramer, MD, University of California, Irvine Medical Center, 101 The City Drive South, Building 53 Room 203, Orange, CA 92868-4280. E-mail scramer{at}uci.edu

Background and Purpose— A number of therapies in development for patients with central nervous system injury aim to reduce disability by improving function of surviving brain elements rather than by salvaging tissue. The current study tested the hypothesis that, after adjusting for a number of clinical assessments, a measure of brain function at baseline would improve prediction of behavioral gains after treatment.

Methods— Twenty-four patients with chronic stroke underwent baseline clinical and functional MRI assessments, received 6 weeks of rehabilitation therapy with or without investigational motor cortex stimulation, and then had repeat assessments. Thirteen baseline clinical/radiological measures were evaluated for ability to predict subsequent trial-related gains.

Results— Across all patients, bivariate analyses found that greater trial-related functional gains were predicted by (1) smaller infarct volume, (2) greater baseline clinical status, and (3) lower degree of activation in stroke-affected motor cortex on baseline functional MRI. When these 3 variables were further assessed using multivariate linear regression modeling, only lower motor cortex activation and greater clinical status at baseline remained significant predictors. Note that lower baseline motor cortex activation was also associated with larger increases in motor cortex activation after treatment.

Conclusions— Lower motor cortex activity at baseline predicted greater behavioral gains after therapy, even after controlling for a number of clinical assessments. The boosts in cortical activity that paralleled behavioral gains suggest that in some patients, low baseline cortical activity represents underuse of surviving cortical resources. A measure of brain function might be important for optimal clinical decision-making in the context of a restorative intervention.


Key Words: functional MRI • plasticity • recovery • stroke


Related Article:

Can fMRI Measures of Brain Motor Activation Add Significantly to Other Variables in the Prediction of Treatment Response?
Isabelle Loubinoux
Stroke 2007 38: 2032-2033. [Full Text] [PDF]



This article has been cited by other articles:


Home page
StrokeHome page
C. Enzinger, H. Johansen-Berg, H. Dawes, M. Bogdanovic, J. Collett, C. Guy, S. Ropele, U. Kischka, D. Wade, F. Fazekas, et al.
Functional MRI Correlates of Lower Limb Function in Stroke Victims With Gait Impairment
Stroke, May 1, 2008; 39(5): 1507 - 1513.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. D. Takahashi, L. Der-Yeghiaian, V. Le, R. R. Motiwala, and S. C. Cramer
Robot-based hand motor therapy after stroke
Brain, February 1, 2008; 131(2): 425 - 437.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. C. Cramer
The EXCITE Trial: A Major Step Forward for Restorative Therapies in Stroke
Stroke, July 1, 2007; 38(7): 2204 - 2205.
[Full Text] [PDF]